Liquid Delivery Device

OptiNose’s breath-powered nasal delivery technology significantly improves delivery to the target sites deep into the nasal cavity. In use, the subject inserts the sealing nozzle of the device into one nostril and blows into the mouthpiece against a resistance. Then the user manually activates the device by pressing the bottom of the bottle, releasing the resistance to the exhaled breath and allowing the exhaled breath and drug particles to create a medication-carrying airflow into the user’s nasal cavity.

To view the video above, you will need the latest version of Adobe Flash.
You can download it here.

User studies have shown a clear preference over traditional nasal sprays.

  • Intuitive and easy to use
  • More comfortable because of its fixed position during use
  • Airflow through the nose at actuation reduces the discomfort often experienced when the spray is released
  • Reduction in the aftertaste at the back of the throat

Nasal Polyps Study Data

OptiNose is beginning clinical trials with its liquid delivery device to gain FDA approval to treat nasal polyps with fluticasone.

View Data

Partnership Opportunities

The OptiNose technology has unique capabilities that may be ideally suited to solving your specific delivery challenges.

LEARN MORE